Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

HIKMA

  • FDA Approval
  • Nov. 18, 2024, 09:58 UTC
  • 47
  • 0 comments

FDA approve ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE

Comment Full text

TEVA PHARMS USA

  • FDA Approval
  • Nov. 18, 2024, 09:58 UTC
  • 42
  • 0 comments

FDA approve LINEZOLID

Comment Full text

ADAPTIS

  • FDA Approval
  • Nov. 18, 2024, 09:58 UTC
  • 50
  • 0 comments

FDA approve DUTASTERIDE

Comment Full text

JUBILANT GENERICS

  • FDA Approval
  • Nov. 18, 2024, 09:58 UTC
  • 41
  • 0 comments

FDA approve CITALOPRAM HYDROBROMIDE

Comment Full text

CHARTWELL MOLECULAR

  • FDA Approval
  • Nov. 18, 2024, 09:58 UTC
  • 39
  • 0 comments

FDA approve SULFADIAZINE

Comment Full text

RISING

  • FDA Approval
  • Nov. 18, 2024, 09:58 UTC
  • 39
  • 0 comments

FDA approve NATEGLINIDE

Comment Full text

CHARTWELL RX

  • FDA Approval
  • Nov. 18, 2024, 09:58 UTC
  • 47
  • 0 comments

FDA approve CITALOPRAM HYDROBROMIDE

Comment Full text

ACTAVIS MID ATLANTIC

  • FDA Approval
  • Nov. 18, 2024, 09:58 UTC
  • 50
  • 0 comments

FDA approve DICLOFENAC SODIUM

Comment Full text

PADAGIS ISRAEL

  • FDA Approval
  • Nov. 18, 2024, 09:58 UTC
  • 50
  • 0 comments

FDA approve ESTRADIOL

Comment Full text

EUGIA PHARMA

  • FDA Approval
  • Nov. 15, 2024, 09:47 UTC
  • 45
  • 0 comments

FDA approve METHYLPREDNISOLONE SODIUM SUCCINATE

Comment Full text
  • Previous
  • 314
  • 315
  • 316
  • 317
  • 318
  • Next

Search

News categories

  • Technical Exchange News(11504)
  • Event(3373)
  • SEC News(216324)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(137418)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin